BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pria AD, Pinato D, Roe J, Naresh K, Nelson M, Bower M. Relapse of HHV8-positive multicentric Castleman disease following rituximab-based therapy in HIV-positive patients. Blood. 2017;129:2143-2147. [PMID: 28143881 DOI: 10.1182/blood-2016-10-747477] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Bernabei L, Waxman A, Caponetti G, Fajgenbaum DC, Weiss BM. AA amyloidosis associated with Castleman disease: A case report and review of the literature. Medicine (Baltimore) 2020;99:e18978. [PMID: 32028407 DOI: 10.1097/MD.0000000000018978] [Reference Citation Analysis]
2 Fajgenbaum DC, June CH. Cytokine Storm. N Engl J Med. 2020;383:2255-2273. [PMID: 33264547 DOI: 10.1056/nejmra2026131] [Cited by in Crossref: 347] [Cited by in F6Publishing: 224] [Article Influence: 347.0] [Reference Citation Analysis]
3 Oksenhendler E, Boutboul D, Galicier L. Kaposi sarcoma-associated herpesvirus/human herpesvirus 8-associated lymphoproliferative disorders. Blood 2019;133:1186-90. [PMID: 30610029 DOI: 10.1182/blood-2018-11-852442] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
4 Beckham TH, Yang JC, Chau KW, Noy A, Yahalom J. Excellent Outcomes with Surgery or Radiotherapy in the Management of Castleman Disease Including a Case of Oligocentric Disease. Clin Lymphoma Myeloma Leuk 2020;20:685-9. [PMID: 32522439 DOI: 10.1016/j.clml.2020.05.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Chappell DL, White MC, Damania B. Proteomic approaches to investigate gammaherpesvirus biology and associated tumorigenesis. Adv Virus Res 2021;109:201-54. [PMID: 33934828 DOI: 10.1016/bs.aivir.2020.10.001] [Reference Citation Analysis]
6 Noy A. HIV multicentric Castleman: rituximab sans maintenance. Blood 2017;129:2045-6. [PMID: 28408420 DOI: 10.1182/blood-2017-03-767558] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Wu YJ, Su KY. Updates on the diagnosis and management of multicentric Castleman disease. Tzu Chi Med J 2021;33:22-8. [PMID: 33505874 DOI: 10.4103/tcmj.tcmj_15_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Ramaswami R, Lurain K, Polizzotto MN, Ekwede I, Waldon K, Steinberg SM, Mangusan R, Widell A, Rupert A, George J, Gonçalves PH, Marshall VA, Whitby D, Wang HW, Pittaluga S, Jaffe ES, Little RF, Uldrick TS, Yarchoan R. Characteristics and outcomes of KSHV-associated multicentric Castleman disease with or without other KSHV diseases. Blood Adv 2021;5:1660-70. [PMID: 33720337 DOI: 10.1182/bloodadvances.2020004058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Liu HL, Fan L, Li JY. [Progress in the diagnosis and treatment of Castleman disease]. Zhonghua Xue Ye Xue Za Zhi 2020;41:697-700. [PMID: 32942829 DOI: 10.3760/cma.j.issn.0253-2727.2020.08.017] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Fajgenbaum DC. Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease. Blood 2018;132:2323-30. [PMID: 30487129 DOI: 10.1182/blood-2018-05-848671] [Cited by in F6Publishing: 29] [Reference Citation Analysis]
11 Ramaswami R, Lurain K, Peer CJ, Serquiña A, Wang V, Widell A, Goncalves P, Steinberg SM, Marshall V, George J, Figg WD, Whitby D, Ziegelbauer J, Uldrick TS, Yarchoan R. Tocilizumab in patients with symptomatic Kaposi sarcoma herpesvirus-associated multicentric Castleman disease. Blood 2020;135:2316-9. [PMID: 32276276 DOI: 10.1182/blood.2019004602] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
12 Fajgenbaum DC. Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease. Hematology Am Soc Hematol Educ Program 2018;2018:318-25. [PMID: 30504327 DOI: 10.1182/asheducation-2018.1.318] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
13 Arenas DJ, Floess K, Kobrin D, Pai RL, Srkalovic MB, Tamakloe MA, Rasheed R, Ziglar J, Khor J, Parente SAT, Pierson SK, Martinez D, Wertheim GB, Kambayashi T, Baur J, Teachey DT, Fajgenbaum DC. Increased mTOR activation in idiopathic multicentric Castleman disease. Blood 2020;135:1673-84. [PMID: 32206779 DOI: 10.1182/blood.2019002792] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
14 Koa B, Borja AJ, Aly M, Padmanabhan S, Tran J, Zhang V, Rojulpote C, Pierson SK, Tamakloe MA, Khor JS, Werner TJ, Fajgenbaum DC, Alavi A, Revheim ME. Emerging role of 18F-FDG PET/CT in Castleman disease: a review. Insights Imaging 2021;12:35. [PMID: 33709329 DOI: 10.1186/s13244-021-00963-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Goodman AM, Jeong AR, Phillips A, Wang HY, Sokol ES, Cohen PR, Sicklick J, Fajgenbaum DC, Kurzrock R. Novel somatic alterations in unicentric and idiopathic multicentric Castleman disease. Eur J Haematol 2021;107:642-9. [PMID: 34431136 DOI: 10.1111/ejh.13702] [Reference Citation Analysis]
16 Liu B, Huang Y, Tang L, Guan J, Zhou X, Zhan H. Inflammatory pseudotumor of Castleman disease and IgG4-related disease masquerading as kidney malignancy. Diagn Pathol 2021;16:74. [PMID: 34376196 DOI: 10.1186/s13000-021-01134-y] [Reference Citation Analysis]
17 Cheng JL, Cui J, Wang Y, Xu ZZ, Liu F, Liang SB, Tian H. Unicentric Castleman disease presenting as a retroperitoneal peripancreatic mass: A report of two cases and review of literature. World J Gastroenterol 2018; 24(34): 3958-3964 [PMID: 30228787 DOI: 10.3748/wjg.v24.i34.3958] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
18 van den Bogaart L, Cipriano A, Koutsokera A, Manuel O. Understanding rare infections post-lung transplantation. Expert Rev Respir Med 2021;15:325-38. [PMID: 33106068 DOI: 10.1080/17476348.2021.1843428] [Reference Citation Analysis]
19 Lurain K, Yarchoan R, Uldrick TS. Treatment of Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease. Hematol Oncol Clin North Am 2018;32:75-88. [PMID: 29157621 DOI: 10.1016/j.hoc.2017.09.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
20 Toscano M, Cristina S, Cipriano P, Alves AR. Misdiagnosing multicentric Castleman's disease in an HIV-positive patient. Rev Assoc Med Bras (1992) 2020;66:401-4. [PMID: 32578769 DOI: 10.1590/1806-9282.66.4.401] [Reference Citation Analysis]
21 Dispenzieri A, Fajgenbaum DC. Overview of Castleman disease. Blood 2020;135:1353-64. [PMID: 32106302 DOI: 10.1182/blood.2019000931] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 31.0] [Reference Citation Analysis]
22 Lomas OC, Streetly M, Pratt G, Cavet J, Royston D, Schey S, Ramasamy K; British Society for Haematology (BSH) Committee. The management of Castleman disease. Br J Haematol 2021. [PMID: 34340261 DOI: 10.1111/bjh.17688] [Reference Citation Analysis]
23 Gonçalves PH, Uldrick TS, Yarchoan R. HIV-associated Kaposi sarcoma and related diseases. AIDS 2017;31:1903-16. [PMID: 28609402 DOI: 10.1097/QAD.0000000000001567] [Cited by in Crossref: 52] [Cited by in F6Publishing: 35] [Article Influence: 17.3] [Reference Citation Analysis]
24 Noy A. HIV Lymphoma and Burkitts Lymphoma. Cancer J 2020;26:260-8. [PMID: 32496459 DOI: 10.1097/PPO.0000000000000448] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Duncan CJA, Charlton FG, Bower M, Price DA. The unholy trinity of human herpesvirus 8-associated malignancy in a person living with HIV-1. AIDS 2018;32:404-6. [PMID: 29309348 DOI: 10.1097/QAD.0000000000001719] [Reference Citation Analysis]
26 Noy A. Optimizing treatment of HIV-associated lymphoma. Blood 2019;134:1385-94. [PMID: 30992269 DOI: 10.1182/blood-2018-01-791400] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
27 Re A, Cattaneo C, Montoto S. Treatment management of haematological malignancies in people living with HIV. Lancet Haematol 2020;7:e679-89. [PMID: 32791044 DOI: 10.1016/S2352-3026(20)30115-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 7.0] [Reference Citation Analysis]